Growth factor regulation of growth factor production by multiple gene transfer to chondrocytes

Shuiliang Shi1, Scott Mercer, George J Eckert

  • 1Department of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, IN 46202-5111, USA.

Insights

Combinations of growth factors interact to regulate each other's production. These complex interactions are crucial for developing effective cell-based therapies for conditions like articular cartilage repair.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Regenerative Medicine

Background:

  • Growth factors regulate numerous cellular processes, but their self-regulation is understudied.
  • Endogenous growth factors hold therapeutic promise for articular cartilage repair.
  • Gene transfer offers a viable method for delivering growth factors in regenerative therapies.

Purpose of the Study:

  • To investigate the hypothesis that combinations of endogenous growth factors interactively regulate the production of other growth factors.
  • To explore the implications of these interactions for developing cell-based therapies for articular cartilage repair.

Main Methods:

  • Adult bovine articular chondrocytes were utilized as the cellular model.
  • Cells were treated with combinations of cDNAs encoding specific growth factors: insulin-like growth factor I, bone morphogenetic protein-2 and -7, transforming growth factor β1, and fibroblast growth factor 2.
  • The production of growth factors by these treated cells was analyzed.

Main Results:

  • Co-expression of growth factor transgenes resulted in mutual regulation of their production.
  • Observed regulatory effects included both stimulation and inhibition of growth factor output.
  • The combined effects of multiple transgenes on growth factor production were not simply additive and could not be predicted from individual transgene actions.

Conclusions:

  • Endogenous growth factors exhibit complex, interactive regulatory relationships.
  • These intricate interactions are critical considerations for selecting appropriate growth factor combinations in gene transfer-based cell therapies.
  • Understanding these growth factor networks is essential for advancing therapeutic strategies, particularly for articular cartilage repair.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Transgenic Plants02:50

Transgenic Plants

Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...